https://russian.lifeboat.com/blog/2020/08/safety-and-pharmacokinetics-of-cxcr4-peptide-antagonist-ly2510924-in-combination-with-durvalumab-in-advanced-refractory-solid-tumors Safeguarding Humanity Sun, 23 Aug 2020 11:22:21 +0000 hourly 1 https://wordpress.org/?v=5.6.1